IL6 and Hyperglycemia: In conditions characterized by high metabolic stress and hyperglycemia such as DKA, investigating the effects of inflammatory markers such as IL-6 on the duration of ICU stay and the general recovery process may contribute to the development of strategies to improve clinical outcomes [7].